KR20010033299A - Ｓａｇ: 아팝토시스 감응성 유전자 - Google Patents

Ｓａｇ: 아팝토시스 감응성 유전자 Download PDF

Info

Publication number
KR20010033299A
KR20010033299A KR1020007006741A KR20007006741A KR20010033299A KR 20010033299 A KR20010033299 A KR 20010033299A KR 1020007006741 A KR1020007006741 A KR 1020007006741A KR 20007006741 A KR20007006741 A KR 20007006741A KR 20010033299 A KR20010033299 A KR 20010033299A
Authority
KR
South Korea
Prior art keywords
seq
sag
cys
cells
val
Prior art date
Application number
KR1020007006741A
Other languages
English (en)
Korean (ko)
Inventor
이 선
Original Assignee
로즈 암스트롱, 크리스틴 에이. 트러트웨인
워너-램버트 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로즈 암스트롱, 크리스틴 에이. 트러트웨인, 워너-램버트 캄파니 filed Critical 로즈 암스트롱, 크리스틴 에이. 트러트웨인
Publication of KR20010033299A publication Critical patent/KR20010033299A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020007006741A 1997-12-19 1998-12-15 Ｓａｇ: 아팝토시스 감응성 유전자 KR20010033299A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6817997P 1997-12-19 1997-12-19
US60/068,179 1997-12-19
US9984098P 1998-09-11 1998-09-11
US60/099,840 1998-09-11
PCT/US1998/026705 WO1999032514A2 (fr) 1997-12-19 1998-12-15 Sag: gene sensible a l'apoptose

Publications (1)

Publication Number Publication Date
KR20010033299A true KR20010033299A (ko) 2001-04-25

Family

ID=26748669

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007006741A KR20010033299A (ko) 1997-12-19 1998-12-15 Ｓａｇ: 아팝토시스 감응성 유전자

Country Status (8)

Country Link
EP (1) EP1044217A2 (fr)
JP (1) JP2001526063A (fr)
KR (1) KR20010033299A (fr)
AU (1) AU765741B2 (fr)
BR (1) BR9813757A (fr)
CA (1) CA2303483A1 (fr)
NZ (1) NZ503417A (fr)
WO (1) WO1999032514A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1165787A2 (fr) * 1999-03-31 2002-01-02 The University of North Carolina at Chapel Hill Adn isole codant pour des regulateurs cullin roc1 et roc2, proteines isolees codees par ledit adn. procedes d'utilisation associes
US7078203B1 (en) 1999-03-31 2006-07-18 The University Of North Carolina At Chapel Hill Isolated DNA encoding cullin regulators ROC1 and ROC2, isolated proteins encoded by the same, and methods utilizing the same
WO2001046468A2 (fr) * 1999-12-21 2001-06-28 Eirx Therapeutics Ltd Technique de recherche
US6979551B2 (en) 2000-04-03 2005-12-27 Rigel Pharmaceuticals, Inc. Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
US6740495B1 (en) 2000-04-03 2004-05-25 Rigel Pharmaceuticals, Inc. Ubiquitin ligase assay
WO2002004657A2 (fr) * 2000-07-07 2002-01-17 Eirx Therapeutics Limited Procede de criblage
IL156557A0 (en) * 2000-12-22 2004-01-04 Janssen Pharmaceutica Nv Bax-responsive genes for drug target identification in yeast and fungi
CN115345122B (zh) * 2022-08-31 2023-03-17 沐曦科技(北京)有限公司 一种用于仿真的非标准总线协议的芯片验证装置

Also Published As

Publication number Publication date
JP2001526063A (ja) 2001-12-18
WO1999032514A2 (fr) 1999-07-01
CA2303483A1 (fr) 1999-07-01
EP1044217A2 (fr) 2000-10-18
AU1918099A (en) 1999-07-12
WO1999032514A3 (fr) 1999-09-10
NZ503417A (en) 2002-12-20
BR9813757A (pt) 2000-10-03
AU765741B2 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
Nobori et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
KR100288749B1 (ko) 종양거부항원 전구체 mage-3을 코딩하는 분리된 핵산분자 및 그것의 사용
JPH09502088A (ja) 細胞死レギュレータ
JPH09504959A (ja) 哺乳動物細胞周期蛋白質
HUT74276A (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
EP1107797A2 (fr) Genes regules par l'hypoxie
US6130317A (en) Bax inhibitor proteins
KR20010033299A (ko) Ｓａｇ: 아팝토시스 감응성 유전자
US6448040B1 (en) Inhibitor of cellular proliferation
WO1998004717A2 (fr) Peptides derives de la proteine kinase dependant de l'arn double brin, utilises pour favoriser la proliferation de cellules et de tissus de maniere controlee
KR20070011892A (ko) Ｍｓｘ1 단백질 또는 이를 코딩하는 유전자를유효성분으로 포함하는 세포사멸유도제
US6171857B1 (en) Leucine zipper protein, KARP-1 and methods of regulating DNA dependent protein kinase activity
EP1201754A1 (fr) Facteur associe a l'apoptose
US7256321B2 (en) Intracellular modulators of apoptopic cell death pathways
JP2002503466A (ja) 網膜芽細胞腫タンパク質複合体および網膜芽細胞腫相互作用タンパク質
EP1007672B1 (fr) Glissieres a leucine induites par un glucocorticoide servant de modulateurs intracellulaires des mecanismes d'apoptose cellulaire
Wang et al. HuBMSC-MCP, a novel member of mitochondrial carrier superfamily, enhances dendritic cell endocytosis
CA2482909A1 (fr) Proteine associee au tocopherol et utilisations de celle-ci
MXPA00003201A (en) Sag:sensitive to apoptosis gene
KR100898866B1 (ko) 원 종양유전자 단백질 ｄｅｋ를 이용하여 세포사멸을유도하는 조성물 및 방법 및 ｄｅｋ를 발현하는 형질전환초파리
JP3993439B2 (ja) Ａｉｐ処理により発現の変化する新規遺伝子群
KR20050098800A (ko) 임포틴 α유전자 및/또는 재조합 ｐ５３ 유전자를 포함하는항암제
JP2005287418A (ja) 細胞殺傷性と細胞死防御性とを併せもつペプチド
JP2003518360A (ja) 哺乳類出血誘導性遺伝子ｋｄ３１２
Vempati et al. The Role of Cytochrome c in Apoptosis: Increased Sensitivity to TNF-α is Associated with Respiratory Defects But Not with Lack of Cytochrome c Release.

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid